Hsu Jason's most recent trade in Immix Biopharma Inc was a trade of 33,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immix Biopharma Inc | Jason Hsu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Jason Hsu | Director | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 20 Dec 2024 | 40,000 | 893,000 | - | 2.2 | 87,680 | Common Stock |
| Immix Biopharma Inc | Hsu Jason | Director | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 20 Dec 2024 | 7,700 | 853,000 | - | 2.2 | 16,678 | Common Stock |
| Immix Biopharma Inc | Jason Hsu | Director | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 21 Aug 2024 | 15,000 | 837,200 | - | 2.2 | 33,390 | Common Stock |
| Immix Biopharma Inc | Jason Hsu | Director | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 21 Aug 2024 | 8,100 | 845,300 | - | 2.3 | 18,233 | Common Stock |
| Immix Biopharma Inc | Jason Hsu | Director | Purchase of securities on an exchange or from another person at price $ 2.15 per share. | 18 Jul 2024 | 6,000 | 822,200 | - | 2.1 | 12,877 | Common Stock |
| Immix Biopharma Inc | Jason Hsu | Director | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 18 Jul 2024 | 3,200 | 816,200 | - | 2.1 | 6,639 | Common Stock |
| Immix Biopharma Inc | Jason Hsu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Jason Hsu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 25,512 | 25,512 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Jason Hsu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 21,587 | 21,587 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Hsu Jason | Director | Purchase of securities on an exchange or from another person at price $ 4.67 per share. | 08 Dec 2023 | 31,000 | 813,000 | - | 4.7 | 144,894 | Common Stock |
| Immix Biopharma Inc | Jason Hsu | Director | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 08 Dec 2023 | 25,000 | 782,000 | - | 4.9 | 122,025 | Common Stock |
| Immix Biopharma Inc | Jason Hsu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 20,000 | 20,000 | - | - | Stock Options | |
| Immix Biopharma Inc | Jason Hsu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 16,000 | 16,000 | - | - | Stock Options | |
| Immix Biopharma Inc | Jason Hsu | Director | 20 Dec 2021 | 3,915,913 | 3,915,913 | - | 0.8 | 3,328,526 | Common Stock | |
| Immix Biopharma Inc | Jason Hsu | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 20 Dec 2021 | 50,000 | 50,000 | - | 5 | 250,000 | Common Stock |